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Hand2 elevates cardiomyocyte production during zebrafish heart
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ABSTRACT
Embryonic heart formation requires the production of an appropriate
number of cardiomyocytes; likewise, cardiac regeneration following
injury relies upon the recovery of lost cardiomyocytes. The basic
helix-loop-helix (bHLH) transcription factor Hand2 has been
implicated in promoting cardiomyocyte formation. It is unclear,
however, whether Hand2 plays an instructive or permissive role
during this process. Here, we find that overexpression of hand2 in
the early zebrafish embryo is able to enhance cardiomyocyte
production, resulting in an enlarged heart with a striking increase in
the size of the outflow tract. Our evidence indicates that these
increases are dependent on the interactions of Hand2 in multimeric
complexes and are independent of direct DNA binding by Hand2.
Proliferation assays reveal that hand2 can impact cardiomyocyte
production by promoting division of late-differentiating cardiac
progenitors within the second heart field. Additionally, our data
suggest that hand2 can influence cardiomyocyte production by
altering the patterning of the anterior lateral plate mesoderm,
potentially favoring formation of the first heart field at the expense
of hematopoietic and vascular lineages. The potency of hand2
during embryonic cardiogenesis suggested that hand2 could also
impact cardiac regeneration in adult zebrafish; indeed, we find that
overexpression of hand2 can augment the regenerative proliferation
of cardiomyocytes in response to injury. Together, our studies
demonstrate that hand2 can drive cardiomyocyte production in
multiple contexts and through multiple mechanisms. These results
contribute to our understanding of the potential origins of congenital
heart disease and inform future strategies in regenerative medicine.
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INTRODUCTION
The assembly of the embryonic heart is a complex procedure
involving the differentiation, migration and organization of the proper
number of cardiomyocytes in order to form a functional contractile
organ. Regulation of the genesis of cardiomyocytes requires the
specification of heart fields with appropriate boundaries, as well as
the controlled proliferation of the progenitor cells that emerge from
these fields. An understanding of the genetic pathways that influence
cardiomyocyte production may illuminate mutations that underlie
congenital heart disease (CHD) (Fahed et al., 2013). Moreover,
cardiomyocyte production, in vitro or in vivo, is a primary goal of
cardiovascular regenerativemedicine, and insight into genes that drive
cardiomyocyte formation can enhance strategies for repairing hearts
damaged bymyocardial infarction (Laflamme andMurry, 2011; Choi
and Poss, 2012; Xin et al., 2013). However, our understanding of the
precise functions of factors that facilitate cardiomyocyte production
remains incomplete.
The bHLH transcription factor Hand2 has been implicated as an
important regulator of cardiomyocyte production. In mice, loss of
Hand2 function results in hypoplasia of the right ventricle and outflow
tract (Srivastava et al., 1997), suggesting that Hand2 promotes the
development of cardiomyocytes derived from the second heart field
(SHF). Furthermore, removal of Hand2 function from the SHF via
tissue-specific deletion of a conditional allele interferes with survival
of this progenitor population (Tsuchihashi et al., 2011). The effects of
loss of Hand2 function are exacerbated when combined with either a
conditional knockout or a hypomorphic allele of the related gene
Hand1, suggesting functional redundancybetweenHand2 andHand1
that could mask earlier or broader roles of these factors in regulating
cardiomyocyte production in mice (McFadden et al., 2005; Firulli
et al., 2010).
In zebrafish, an early requirement for hand2 during cardiomyocyte
production has been clearly demonstrated. Zebrafish hand2 mutants
display a striking cardiac phenotype that features a dramatic deficit of
cardiomyocytes (Yelon et al., 2000). This defect is evident from an
early stage, as indicated by a substantial reduction in the number of
cells that initiate expression of myocardial differentiation markers.
Fate mapping has shown that hand2 expression demarcates the heart-
forming region within the anterior lateral plate mesoderm (ALPM),
and, in hand2 mutants, the progenitors residing in this region are
ineffective at generating differentiated cardiomyocytes (Schoenebeck
et al., 2007). Thus, hand2 is important for facilitating cardiomyocyte
production. However, it is not clear whether hand2 regulates
cardiomyocyte production by influencing cell fate decisions or by
affecting proliferative capacity, nor is it known whether hand2 plays
an instructive or a permissive role in this setting.
The possibility that Hand2 instructively directs cardiomyocyte
production has been highlighted by recent studies in which forced
expression of Hand2 was shown to increase the efficiency of
reprogramming mammalian fibroblasts toward a myocardial fate
(Song et al., 2012; Nam et al., 2013). Introduction of Hand2,
Gata4, Mef2c and Tbx5 into neonatal mouse fibroblasts increased
the frequency of reprogramming approximately three- to fourfold
over that observed with introduction of only Gata4, Mef2c and
Tbx5 (Song et al., 2012). Additionally, in human fibroblasts,
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contractile gene expression programs during reprogramming,
whereas other factors, such as Gata4, Mef2c, Tbx5 and Myocd,
play redundant roles in this regard (Nam et al., 2013). Thus, Hand2
can play a pivotal part in enhancing protocols for cardiac
regeneration and repair; however, little is known about how
forced expression of Hand2 mediates this role.
To gain new insight into the ability of Hand2 to drive
cardiomyocyte production, we have examined the effects of hand2
overexpression on the embryonic and adult zebrafish heart. We find
that overexpression of hand2 in the early embryo can increase
cardiomyocyte numbers, with a particularly striking impact on the
size of the cardiac outflow tract. Our data suggest that this cardiac
enlargement results from increased progenitor proliferationwithin the
SHF, as well as from increased cardiomyocyte specification within
the first heart field (FHF). In addition, we find that overexpression of
hand2 in the adult heart enhances myocardial proliferation following
injury. Together, our data suggest that hand2 can play important and
instructive roles in elevating cardiomyocyte production in multiple
contexts: by promoting specification of FHF cardiomyocytes, by
enhancing proliferation of SHF cardiac progenitors and by
augmenting proliferation of regenerating cardiomyocytes. These
results refine our understanding of the origins of CHD, particularly in
the context of partial trisomy distal 4q, which involves duplication of
HAND2 (Tamura et al., 2013).Moreover, our findings highlight ways
in which hand2 overexpression could facilitate future approaches for
cardiac regeneration and repair.
RESULTS
Overexpression of hand2 increases cardiomyocyte
production
To determine whether increased hand2 function can enhance
cardiomyocyte production, we injected zebrafish embryos with
hand2mRNA. Although we have previously injected hand2mRNA
into wild-type embryos (Yelon et al., 2000; Garavito-Aguilar et al.,
2010), our prior studies did not closely examine its impact on heart
size. Here, we found that injected embryos exhibited expanded
expression of cmlc2, a marker of differentiated cardiomyocytes,
within the ALPM at 18 somites (Fig. 1A,B). Measurements of the
region of cmlc2 expression revealed a significant increase in area
within the hand2-overexpressing embryos (Fig. 1E). To examine
whether increased hand2 expression leads to enhanced heart size
at later stages, we injected hand2 mRNA into embryos carrying
Tg(-5.1myl7:nDsRed2) (Mably et al., 2003), which facilitates
quantification of fluorescent cardiomyocyte nuclei, and counted
the number of cardiomyocytes present in the heart at 36 h post-
fertilization (hpf). We found a significant increase in cardiomyocyte
number in embryos overexpressing hand2 (Fig. 1F). Together, these
data suggest that increased expression of hand2 can expand the
heart-forming region within the ALPM, leading to a larger heart.
However, hand2 overexpression did not induce cmlc2 expression
outside the ALPM, indicating that cardiomyocyte production
depends on the interaction of Hand2 with other ALPM factors.
The influence of Hand2 on cardiomyocyte production is
dependent on protein-protein interactions and not on direct
DNA binding
Previous studies have shown that Hand2 can function independently
of direct DNA binding in some contexts (McFadden et al., 2002;
Liu et al., 2009). Mice in which the Hand2 gene was replaced with
a DNA binding-deficient form ofHand2 exhibited relatively normal
hearts at E11.5 (Liu et al., 2009), in contrast to the severe ventricular
hypoplasia seen inHand2mutants byE10.5 (Srivastava et al., 1997).
It is presumed that the DNA binding-deficient form of Hand2
can influence transcription through dimerization with other bHLH
factors, as well as through interactions with larger protein complexes
(Rychlik et al., 2003; Xu et al., 2003). To test whether the early role
of hand2 during cardiomyocyte production is dependent on DNA
binding or dimerization, we evaluated whether previously
characterized DNA binding-deficient and dimerization-deficient
versions of Hand2 can expand cmlc2 expression.
Replacement of three arginines (residues 109-111) in the basic
domain of mouse Hand2 with acidic residues [glutamic acid,
aspartic acid and glutamic acid (EDE)] has been shown to abolish
DNA binding (McFadden et al., 2002; Liu et al., 2009). This region
is highly conserved between mouse and zebrafish (supplementary
material Fig. S1): 98% of the amino acids in the basic helix-loop-
helix domain are identical, including these three arginine residues
(100-102 in zebrafish). In addition, replacement of a phenylalanine
(residue 119) with a proline in the first helix of mouse Hand2 has
been shown to disrupt its dimerization (McFadden et al., 2002). This
highly conserved amino acid is present in zebrafish Hand2 (F110;
supplementary material Fig. S1). Extrapolating from prior work in
Fig. 1. hand2 overexpression increases cardiomyocyte
production. (A-D) In situ hybridization depicts cmlc2 expression at
18 somites in (A) wild-type embryos, (B) hand2-overexpressing
embryos (hand2 OE), (C) embryos expressing a DNA binding-
deficient form of hand2 (hand2 EDE) and (D) embryos expressing a
dimerization-deficient form of hand2 (hand2 P); dorsal views,
anterior upwards. Broader expression of cmlc2 is found within the
ALPM of embryos overexpressing hand2 or hand2 EDE.
(E) Average area of cmlc2 expression, in arbitrary units, in wild-type
embryos and in embryos overexpressing hand2, hand2 EDE or
hand2 P. Error bars indicate s.d.; asterisks indicate significant
differences from wild type. Overexpression of hand2 or hand2 EDE
increases area of cmlc2 expression (n=13-25; *P<0.001), whereas
overexpression of hand2 P does not (n=11; P=0.87). (F) Bar
graph compares average number of cardiomyocytes at 36 hpf
in wild-type embryos and in embryos overexpressing hand2.
Error bars indicate s.d.; asterisk indicates a significant increase
compared with wild type (n=17-19; *P<0.001).
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mouse, we constructed corresponding variants of zebrafish hand2
and injected mRNA encoding each variant into wild-type embryos.
Overexpression of the DNA binding-deficient form of hand2
(hand2 EDE) expanded the area of cmlc2 expression in a manner
similar to the overexpression of wild-type hand2 (Fig. 1A-C,E).
However, overexpression of the dimerization-deficient version of
hand2 (hand2 P) did not expand the cmlc2 expression domain
(Fig. 1A,D,E). Furthermore, injection of hand2 EDE mRNA
substantially rescued cmlc2 expression in embryos homozygous for a
null allele of hand2 (hans6) (Yelon et al., 2000), reminiscent of the
effects of injectingwild-type hand2 into hans6mutants (Fig. 2A-D,F).
By contrast, injection of hand2 P mRNA did not alter cmlc2
expression in hans6 mutants (Fig. 2B,E,F). These results suggest that
Hand2 dimerization, but not its direct binding to DNA, is necessary
for its influence on cardiomyocyte production.
Induction of hand2 overexpression after gastrulation
expands cardiomyocyte production
In some embryos injected with hand2 mRNA, we observed
morphological defects that could result from abnormal gastrulation,
such as shortened body axis or abnormal body curvature. To bypass
effects on gastrulation, we established an inducible system for hand2
overexpression.We constructed a series of transgenes inwhich hand2
is transcribed under the control of the hsp70 heat shock promoter
(Halloran et al., 2000). In these transgenes, we connected Hand2 to
mCherry using the viral 2A peptide sequence that allows separate
stoichiometric translation of both proteins in order to facilitate
monitoring of transgene expression after heat shock (Provost et al.,
2007; Covassin et al., 2009).
In embryos carrying Tg(hsp70:FLAG-hand2-2A-mCherry)
[hereafter referred to as Tg(hsp70:hand2)], induction of hand2
overexpression after gastrulation was sufficient to cause a cardiac
phenotype similar to that caused by mRNA injection at the one-cell
stage. After heat shock at 10 hpf (tail bud stage), transgenic embryos
overexpressing hand2 exhibited a significant expansion in cmlc2
expression at 18 somites (Fig. 3A,B,E), as well as a significant
increase in cardiomyocyte number at 36 hpf (Fig. 3F), compared
with their heat-shocked nontransgenic siblings. Heat-shocked
transgenic embryos also displayed a pronounced pericardial
edema (supplementary material Fig. S2A,B) and an enlarged
heart with a noticeably extended outflow tract (Fig. 3G,I). In
contrast to the consequences of hand2 induction at 10 hpf, induction
of hand2 overexpression at 24 hpf resulted in an embryo without
evident pericardial edema (supplementary material Fig. S2C) or
outflow tract enlargement (Fig. 3H). These data suggest that hand2
has a potent influence on cardiomyocyte production between 10 and
24 hpf, after gastrulation and before the initial assembly of the
heart tube.
The cardiac expansion induced by hand2 overexpression
requires phosphorylation-independent dimerization of
Hand2
The consequences of injection of the hand2 EDE and hand2 P
mRNAs suggest that the role of Hand2 during cardiomyocyte
production requires its dimerization but not its direct binding to
DNA (Fig. 2). Phosphorylation of conserved threonine and serine
residues within the first helix of Hand factors has previously been
shown to be important for their choice of dimerization partners
(Firulli et al., 2003, 2005). For example, changes in phosphorylation
of T107 and S109 of mouse Hand1 influence the affinity for
formation of Hand1-Hand1 homodimers relative to the formation of
Hand1 heterodimers with E proteins (Firulli et al., 2003). To
determine whether the dimerization interactions that influence
cardiomyocyte production require Hand2 phosphorylation, we
constructed the transgene Tg(hsp70:FLAG-hand2AA-2A-mCherry)
[referred to as Tg(hsp70:hand2AA)]. The zebrafish Hand2 variant
Fig. 2. Influence of Hand2 on cardiomyocyte production is dependent on dimerization and not on direct DNA binding. (A-E) In situ hybridization
depicts cmlc2 expression at 21 somites in (A) wild-type embryos, (B) hans6 mutant embryos, (C) hans6 mutant embryos injected with hand2 mRNA, (D) hans6
mutant embryos injected with hand2 EDEmRNA and (E) hans6mutant embryos injected with hand2 PmRNA; dorsal views, anterior upwards. The hans6mutation
is a null allele of hand2 resulting from a deletion that removes the entire hand2 gene (Yelon et al., 2000). At this stage, wild-type cardiomyocytes have formed a ring
(A), whereas few cardiomyocytes have formed in the hans6 mutants (B). Cardiomyocyte formation is substantially rescued with the injection of hand2 (C) or
hand2 EDE (D) mRNA, but not of hand2 PmRNA (E). (F) Average area of cmlc2 expression, as in Fig. 1E. Asterisks indicate significant differences between the
phenotype of hans6 mutant embryos and the phenotypes of hans6 mutant embryos overexpressing versions of hand2. Overexpression of hand2 or hand2 EDE
partially rescues the area of cmlc2 expression in hans6 mutants (n=14; *P<0.001), whereas hand2 P does not (n=14; P=0.085).
3114











expressed by this transgene features substitution of the residues
T103 and S105 with alanines (supplementary material Fig. S1),
thereby preventing their phosphorylation; extrapolating from prior
studies of Hand1 and Twist1, these changes may promote affinity
for homodimerization rather than heterodimerization with E
proteins (Firulli et al., 2003, 2005).
We compared the effects of inducing expression of hand2,
hand2AA and hand2P, using inducible transgenes to overexpress
each variant (supplementary material Fig. S3). Induction of
expression of the phosphorylation-deficient version of hand2 at
10 hpf resulted in expansion of cmlc2 expression at 18 somites,
similar to the effects of inducing wild-type hand2 expression
(Fig. 3A,B,D,E). Likewise, overexpression of the phosphorylation-
deficient version of hand2 caused formation of an enlarged heart
and an elongated outflow tract by 36 hpf, as is the case for
overexpression of wild-type hand2 (Fig. 3G,I,K). By contrast,
induction of expression of the dimerization-deficient version of
hand2 did not expand the area of cmlc2 expression (Fig. 3C,E) and
did not yield a larger heart or outflow tract (Fig. 3J). These data
suggest that an unphosphorylated form of Hand2 mediates its
dimerization and role in the context of cardiac expansion.
Increased proliferation in late-differentiating cells
contributes to cardiac expansion in embryos overexpressing
hand2
The enlarged hearts in embryos overexpressing hand2 led us to
investigate the cellular mechanism through which hand2 influences
cardiomyocyte expansion. As overexpression of Hand1 has been
shown to enhance proliferation within the outflow tract in mice
(Risebro et al., 2006), we were especially interested in determining
the origins of the elongated outflow tract in hand2-overexpressing
embryos. First, we examined the expression of mef2cb at 36 hpf; at
this stage, mef2cb marks a population of SHF-derived cells that
contributes to the outflow tract (Lazic and Scott, 2011; Hinits et al.,
2012). We found excessmef2cb expression at the arterial pole of the
heart in hand2-overexpressing embryos (Fig. 4A-D), suggesting
that the observed outflow tract expansion is the product of excess
SHF-derived cells, rather than simply a morphological anomaly.
In addition, mef2cb expression in embryos overexpressing the
phosphorylation-deficient and dimerization-deficient versions of
hand2 correlated with the observed outflow tract morphologies:
embryos overexpressing hand2 AA exhibited an excess of mef2cb-
expressing cells (Fig. 4G,H), whereas embryos overexpressing
hand2 P did not (Fig. 4E,F). In contrast to their expanded mef2cb
expression at the arterial pole, hand2-overexpressing embryos
exhibited a normal pattern of islet1 expression at the venous pole
(supplementary material Fig. S4), suggesting that hand2 has a more
potent influence on outflow tract formation than on inflow tract
formation.
Next, we employed an EdU incorporation assay to investigate
whether the expansion of the outflow tract or the general increase in
cardiomyocyte number could be the result of increased proliferation in
hand2-overexpressing embryos. Following heat shock at 10 hpf, we
pulsed embryos with EdU for 30 min when they reached 17 hpf,
thereby labeling proliferating cells during that interval (Fig. 5G). We
then compared the numbers of EdU-positive and EdU-negative
cardiomyocytes at 36 hpf in Tg(hsp70:hand2) embryos and their
nontransgenic siblings (Fig. 5A-F). Strikingly, we found a
significantly higher proliferation index in the hand2-overexpressing
cardiomyocytes (Fig. 5H), indicating that increased proliferation
Fig. 3. Cardiac expansion induced by hand2
overexpression requires phosphorylation-
independent dimerization of Hand2.
(A-D) In situ hybridization depicts cmlc2
expression at 18 somites in (A) nontransgenic
embryos, (B) Tg(hsp70:hand2) embryos,
(C) Tg(hsp70:hand2P) embryos and (D)
Tg(hsp70:hand2AA) embryos, heat-shocked at
10 hpf; dorsal views, anterior upwards.
(E) Average area of cmlc2 expression, as in
Fig. 1E, in nontransgenic and transgenic
embryos, following heat shock at 10 hpf.
Asterisks indicate significant differences from
nontransgenic embryos. Overexpression of
hand2 or hand2 AA increases the area of
cmlc2 expression (n=15-32; *P<0.001),
whereas hand2 P does not (n=13; P=0.05).
(F) Average number of cardiomyocytes at
36 hpf, as in Fig. 1F, in nontransgenic embryos
and in Tg(hsp70:hand2) embryos, following
heat shock at 10 hpf. Asterisk indicates a
significant difference from nontransgenic
embryos (n=16-20; *P<0.001). (G-K)
Immunofluorescence at 36 hpf forMF20 (green,
visible in the ventricle) and S46 (red, visible in
the atrium) shows cardiac morphology. Frontal
views; bracketsmark the outflow tract. Hearts of
Tg(hsp70:hand2) embryos heat-shocked at
24 hpf (H) resemble nontransgenic hearts heat-
shocked at 10 hpf (G). Tg(hsp70:hand2)
embryos heat-shocked at 10 hpf (I) show an
overall increase in cardiac size and an enlarged
outflow tract. Similar morphology is seen after
heat shock at 10 hpf in Tg(hsp70:hand2AA)
embryos (K), but not in Tg(hsp70:hand2P)
embryos (J).
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contributes to the enhanced cardiomyocyte production in these
embryos. By contrast, in a parallel set of experiments in which
we pulsed embryos with EdU at 23 hpf (supplementary material
Fig. S5A-G), we did not detect an increased proliferation index in
hand2-overexpressing cardiomyocytes (supplementary material
Fig. S5H), suggesting that hand2 overexpression influences
proliferation prior to 23 hpf.
Based on this series of results, we hypothesized that increased
proliferation in hand2-overexpressing embryos occurs between
17 hpf and the time of initial heart tube assembly. To test this, we
pulsed embryos with EdU at 17 hpf and analyzed the distribution
of EdU-positive cells at 26 hpf in hand2-overexpressing and
nontransgenic embryos (Fig. 6A-E). In addition to scoring
EdU-positive cardiomyocytes, we used Tg(nkx2.5:ZsYellow) to
facilitate scoring of EdU labeling in SHF-derived progenitor cells
that reside near the arterial pole of the early heart tube and
ultimately contribute to the outflow tract (Zhou et al., 2011); these
progenitor cells express Tg(nkx2.5:ZsYellow) but do not yet
express high levels of other myocardial differentiation markers. In
these experiments, we found that hand2 overexpression caused a
significant increase in the proliferation index of the SHF-derived
cardiac progenitor cells near the arterial pole (Fig. 6F). However,
hand2 overexpression did not enhance the proliferation index of
the first heart field-derived (FHF-derived) cardiomyocytes that
form the initial heart tube (Fig. 6F); we obtained similar results
when assessing the cardiomyocyte proliferation index in embryos
pulsed with EdU at 17 hpf and fixed at 23 hpf, and in embryos
pulsed with EdU at 14 hpf and fixed at 26 hpf (supplementary
material Fig. S6). Altogether, our data demonstrate that
overexpression of hand2 has a potent and early impact on the
proliferation of the SHF-derived, late-differentiating progenitor
cells that will create the outflow tract.
Overexpression of hand2 alters ALPM patterning
Although our results suggest that enhanced proliferation of
SHF-derived progenitors contributes to the enlarged outflow tract
seen when hand2 is overexpressed, increased proliferation within
the SHF may not account for all of the enhanced cardiomyocyte
production in hand2-overexpressing embryos. Notably, the increased
area of cmlc2 expression observed at 18 somites (Fig. 3A,B,E)
seems to reflect increased production of cardiomyocytes by the
FHF, as only early-differentiating, FHF-derived cells are thought to
express cmlc2 at this stage (de Pater et al., 2009). Additionally, we
have found increased numbers of differentiated cardiomyocytes in
hand2-overexpressing embryos at 23 hpf (nontransgenic embryos,
127±25 cardiomyocytes; hand2-overexpressing embryos, 164±39
cardiomyocytes; n=9 or 10, P<0.05) and at 26 hpf (nontransgenic
embryos, 154±25 cardiomyocytes; hand2-overexpressing embryos,
224±47 cardiomyocytes; n=10 or 11, P<0.001). As is the case at 18
somites, it is thought that cardiomyocytes have not yet been added
from the SHF at 23 or 26 hpf (de Pater et al., 2009; Lazic and Scott,
2011). Furthermore, we did not detect an increased proliferation
index in the cardiomyocyte population at 23 or 26 hpf (Fig. 6F;
supplementary material Fig. S6F). Together, these data suggest that
the early expansion of cardiomyocytes in hand2-overexpressing
embryos reflects an influence of hand2 on the early-differentiating
FHF, and that this effect is more likely to be the result of altered
specification than of altered proliferation.
To evaluate whether overexpression of hand2 alters the
patterning of the ALPM, we examined markers of lineages that
are neighbors of the heart fields at early stages. scl and etsrp are
expressed in progenitors of the blood and vessel lineages that are
rostral to the heart-forming region that expresses hand2
(Schoenebeck et al., 2007). When blood and vessel lineage
specification are inhibited by loss of scl and etsrp function, hand2
expression expands into the rostral ALPMand an increased number
of cardiomyocytes form (Schoenebeck et al., 2007; Palencia-Desai
et al., 2011). These findings suggest that scl and etsrp act to limit
the extent of myocardial specification in the ALPM. Conversely,
we found that overexpression of hand2 limited the expression of
anterior hematopoietic and endothelial markers at 12 somites,
including scl, etsrp and pu.1 (Fig. 7A-F); even so, these gene
expression defects did not seem to cause major anomalies in
vascular patterning or in endocardial development (supplementary
material Fig. S7). At the same time, hand2-overexpressing
embryos exhibited expanded expression of mef2cb (Fig. 7G,H),
which is found in myocardial progenitor cells at this stage (Hinits
et al., 2012). However, not all myocardial progenitor markers are
similarly expanded, as we found that hand2-overexpressing
embryos exhibit normal expression of nkx2.5 at 12 somites
(Fig. 7I,J). This result suggests that hand2 functions downstream
of nkx2.5, which is consistent with the normal nkx2.5 expression
pattern observed in hand2 mutant embryos (Yelon et al., 2000;
Schoenebeck et al., 2007). Finally, gata4 expression also appeared
Fig. 4. Overexpression of hand2 causes outflow tract
expansion. (A-H) MF20 antibody staining (red) andmef2cb
in situ hybridization (green) at 36 hpf in (A,B)
nontransgenic, (C,D) Tg(hsp70:hand2), (E,F) Tg(hsp70:
hand2P) and (G,H) Tg(hsp70:hand2AA) embryos, all of
which were heat-shocked at 10 hpf. Frontal views; (A,C,E,G)
partial reconstructions of confocal z-stacks with arrows
indicating outflow tract; (B,D,F,H) single slices with brackets
marking outflow tract. Embryos overexpressing hand2 (C,D)
or hand2 AA (G,H) exhibit expanded populations ofmef2cb-
expressing cells, whereas embryos overexpressing hand2 P
(E,F) do not.
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similar in nontransgenic and hand2-overexpressing embryos
(Fig. 7K,L), indicating that increased hand2 expression does not
alter the overall dimensions of the ALPM. Thus, in addition to a
later capacity to promote proliferation within the SHF, hand2
overexpression can influence early patterning processes within the
ALPM, possibly by promoting myocardial specification while
limiting hematopoietic and endothelial specification.
Overexpression of hand2 augments cardiomyocyte
proliferation during cardiac regeneration
Mechanisms of embryonic heart development have served as
necessary guides for understanding cardiac regeneration. The potent
effects of hand2 in the early embryo raise the possibility that its
expression could influence the efficacy of regeneration in the
injured adult heart. In the zebrafish, cardiac injuries are repaired
through a process in which spared mature cardiomyocytes reduce
indicators of differentiation and proliferate to regenerate lost muscle,
involving induction and function of gata4 in source cardiomyocytes
(Jopling et al., 2010; Kikuchi et al., 2010; Gupta et al., 2013). In
previous studies, we also observed increased expression of nkx2.5,
tbx5 and tbx20 in the injury site following resection of the adult
zebrafish ventricle (Lepilina et al., 2006), although the induction of
these genes was not detectable by others (Raya et al., 2003; Jopling
et al., 2010). We additionally found activation of hand2 and gata5
regulatory sequences in endocardial cells after resection injury
(Kikuchi et al., 2011a). To assess gene expression after a more
severe injury, we employed transgene-driven cardiomyocyte
ablation in Z-CAT transgenic fish, in which the combination of
Tg(cmlc2:CreER) and Tg(β-actin2:loxp-mCherry-STOP-loxp-
DTA) transgenes permits 4-HT-inducible expression of diphtheria
toxin in cardiomyocytes (Wang et al., 2011). Enhanced expression
of hand2, as well as nkx2.5, tbx5 and tbx20, was evident in spared
cardiomyocytes throughout the injured Z-CAT ventricle (Fig. 8A-H).
Additionally, fluorescence in Tg(hand2:EGFP) myocardium and
endocardium was boosted during regeneration (Fig. 8I-K), indicating
that cardiac injury can activate hand2 regulatory sequences inmultiple
cell types.
To test whether induced hand2 expression in adult cardiomyocytes
affects their regenerative capacity, we first examined cardiomyocyte
proliferation in injured Z-CAT animals heterozygous for the hans6
mutation (Yelon et al., 2000). Heterozygosity for hans6 did not alter
levels of ablation-induced cardiomyocyte proliferation, although we
also did not detect reduced levels of hand2 mRNA in injured
heterozygous hearts (data not shown). To artificially increase
hand2 expression in cardiomyocytes after injury, we generated a
new transgene that permits 4-HT-inducible hand2 expression,
Tg(β-actin2:loxp-mCherry-STOP-loxp-hand2) [hereafter referred
to as Tg(β-actin2:RSH)]. In fish carrying Tg(β-actin2:RSH) in
combination with Tg(cmlc2:CreER), a single 4-HT injection
sharply increased myocardial hand2 expression but had no effect on
cardiomyocyte proliferation in the absence of injury (data not shown).
In Z-CAT animals carrying Tg(β-actin2:RSH), we experimentally
elevated hand2 levels in spared cardiomyocytes in concert with
inducing ablation injury (Fig. 9A). Under these conditions, we
observed a 34% increase in cardiomyocyte proliferation in Z-CAT;
Tg(β-actin2:RSH) animals at 7 days post-injection (dpi), compared
with that seen in Z-CAT animals at the same timepoint (Fig. 9B). To
confirm effects of hand2 on regenerative proliferation, we induced
hand2 overexpression in Tg(cmlc2:CreER); Tg(β-actin2:RSH)
animals by injecting 4-HT 5 days before performing ventricular
resection. In these experiments, we observed a 102% increase in
cardiomyocyte proliferation at the resection plane, compared with
the proliferation observed in vehicle-injected Tg(cmlc2:CreER);
Tg(β-actin2:RSH) animals (Fig. 9C-E). In total, our results indicate
that elevation of hand2 expression helps boost cardiomyocyte
production during regeneration, mirroring its effect in the embryo.
DISCUSSION
Taken together, our studies demonstrate three distinct mechanisms
through which hand2 overexpression can promote enhanced
cardiomyocyte production. First, overexpression of hand2 results
in expansion of cardiomyocyte production within the early
differentiating FHF, potentially by promoting myocardial
specification at the expense of neighboring blood and vessel
lineages. Second, hand2 overexpression causes excess proliferation
of cardiac progenitor cells within the late-differentiating SHF,
leading to the formation of an abnormally elongated outflow tract.
Third, induced myocardial expression of hand2 enhances
regenerative proliferation of cardiomyocytes in response to injury.
Fig. 5. Increased proliferation contributes to cardiac expansion in hand2-
overexpressing embryos. (A-F) EdU incorporation in hearts of (A-C)
nontransgenic and (D-F) Tg(hsp70:hand2) embryos at 36 hpf, following heat
shock at 10 hpf and EdU pulse at 17 hpf. Partial reconstructions of confocal
z-stacks with ventricle upwards (A,C,D,F) and representative single slices
(B,E). (A,D) White dots indicate EdU-positive (red) cells that are also
MF20-positive (green) differentiated cardiomyocytes. (B,E) Arrows indicate
EdU-positive cells that are also MF20 positive; DAPI (blue) marks all nuclei.
(C,F) White dots indicate all myocardial nuclei. Qualitative assessment
suggests increased numbers of EdU-positive cardiomyocytes in hand2-
overexpressing hearts (D,E), particularly in the distal region of the ventricle and
the outflow tract. (G) Timeline of experimental design. (H) Proliferation indices
in nontransgenic (mCherry-negative) and Tg(hsp70:hand2) (mCherry-
positive) embryos; error bars indicate s.d. Proliferation index was calculated by
dividing the number of EdU-positive cardiomyocytes by the total number of
cardiomyocytes. A significant increase in proliferation index was evident in
hand2-overexpressing embryos (n=8 or 9; *P<0.001).
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Our previous studies have shown that loss of hand2 function
dramatically reduces the cardiomyocyte population, emphasizing
the necessity of hand2 for efficient cardiomyocyte production
(Yelon et al., 2000; Schoenebeck et al., 2007). Integrating our
current and past work, we conclude that hand2 plays important and
instructive roles in promoting cardiomyocyte production via
influences on both specification and proliferation.
Our data indicate that overexpression of hand2 is sufficient to
induce ectopic cardiomyocyte formation in a region proximal to the
typical FHF, but we do not find ectopic cardiomyocytes elsewhere
within hand2-overexpressing embryos. Additionally, while hand2
overexpression is capable of hindering the expression of blood and
vessel markers, hand2-null embryos do not exhibit expanded
expression of blood and vessel genes (Schoenebeck et al., 2007).
These findings suggest that other factors partner with Hand2 to
promote myocardial specification in the FHF and that expression of
these factors is restricted to a particular region of the ALPM. The
significance of the partnerships between Hand2 and other factors is
reinforced by our data demonstrating that the effects of hand2
overexpression on cardiomyocyte production appear to be
independent of direct binding of DNA by Hand2 and dependent
on Hand2 dimerization. It will be valuable for future studies to
investigate which Hand2 dimerization partners are relevant to its
influences on ALPM patterning.
In addition to an instructive role forhand2during specificationof the
FHF, our data suggest a previously unappreciated role for hand2 in
promoting progenitor proliferation within the SHF. Hand factors have
been shown to have roles in both promoting and inhibitingproliferation
Fig. 7. hand2 overexpression limits expression of blood and vessel genes within the ALPM. (A-L) In situ hybridization depicts expression of (A,B) scl, (C,D)
etsrp, (E,F) pu.1, (G,H)mef2cb, (I,J) nkx2.5 and (K,L) gata4 in (A,C,E,G,I,K) nontransgenic embryos and (B,D,F,H,J,L) Tg(hsp70:hand2) embryos following heat
shock at 10 hpf. Dorsal views, anterior upwards, at (A-J) 12 somites and (K,L) 10 somites. Overexpression of hand2 results in (A-F) decreased distribution of scl,
etsrp and pu.1 expression, as well as (G,H) increased expression of mef2cb. By contrast, expression of (I,J) nkx2.5 and (K,L) gata4 appear relatively normal
in hand2-overexpressing embryos at these stages.
Fig. 6. Overexpression of hand2 increases proliferation of SHF-derived progenitor cells. (A-D) EdU incorporation in (A,B) nontransgenic and (C,D)
Tg(hsp70:hand2) embryos at 26 hpf, following heat shock at 10 hpf and EdU pulse at 17 hpf; partial reconstructions of confocal z-stacks with ventricle upwards.
(A,C) White dots indicate EdU-positive (red) cells that are MF20 positive (green) and/or expressing Tg(nkx2.5:ZsYellow) (yellow). (B,D) White dots indicate
all nuclei (DAPI, blue) of cells that are MF20 positive and/or expressing Tg(nkx2.5:ZsYellow). (E) Timeline of experimental design. (F) Proliferation indices, as in
Fig. 5H, for two populations of cells: SHF-derived cells, defined as Tg(nkx2.5:ZsYellow)-expressing cells with very low or no MF20 staining; and FHF-derived
cells, defined as cells with clearly detectable MF20 staining. Proliferation index was calculated for each population independently by dividing the number of
EdU-positive cells by the total number of cells in the population. A significant increase in proliferation index was evident in the SHF-derived cells in hand2-
overexpressing embryos (n=10 or 11; *P=0.003), but not in the FHF-derived cells (n=10 or 11; P=0.528).
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(Risebro et al., 2006; Li et al., 2011), but this particular role ofhand2 in
the SHF has not been demonstrated by prior studies. The impact of
hand2 on SHF progenitor proliferation contrasts with previous work
that found a role for Hand2 in promoting survival of SHF progenitor
cells (Tsuchihashi et al., 2011); although proliferation defects were not
documented in these studies of conditionalHand2 knockoutmice, it is
possible that deficient SHF proliferation preceded the observed death
of SHF cells in these embryos.Additionally, it is interesting to compare
the effects of hand2 overexpression on the zebrafish SHF with the
phenotype of mouse mutants in which Hand1-expressing cells were
engineered to overexpressHand1 (Risebro et al., 2006). In these mice,
increased proliferation was seen in the distal outflow tract, but no
expansion of SHF progenitor markers was observed, suggesting that
Hand1 overexpression did not increase proliferation within the SHF
itself but instead within the cardiomyocytes present or arriving at the
outflow tract (Risebro et al., 2006). These effects of Hand1
overexpression on outflow tract proliferation seem distinct from our
observed effects of hand2 overexpression on the SHF progenitor
Fig. 9. Overexpression of hand2 boosts
cardiomyocyte proliferation in response to injury.
(A) Schematic representation of transgenes used for
cardiomyocyte ablation and myocardium-specific hand2
overexpression in Z-CAT fish. (B) Proliferation indices for
ventricular cardiomyocytes; error bars indicate s.e.m.
Proliferation was assessed 7 days after 4-HT injection in
Z-CAT fish with or without induced cardiomyocyte-
specific hand2 overexpression. hand2-overexpressing
fish exhibited significantly increased proliferation
following ablation injury (n=9 or 10; *P<0.05).
(C) Proliferation indices in injured cmlc2:CreER; β-act2:
RSH fish; error bars indicate s.e.m. Proliferation was
assessed at the resection plane 7 days post-amputation
(dpa) in animals that were injected with either vehicle
or 4-HT 5 days before injury. hand2-overexpressing
fish exhibited significantly increased proliferation
following resection injury (n=4 or 5; *P<0.005).
(D,E) Representative examples of cardiomyocyte
proliferation at 7 dpa at the resection plane (brackets) in
injured cmlc2:CreER; β-act2:RSH fish that were treated
with vehicle (D) or 4-HT (E). Mef2 (green) marks
cardiomyocytes and PCNA (red) marks proliferating
cells; arrows in insets indicate double-positive cells.
Fig. 8. Cardiac injury induces hand2 expression.
(A-H) In situ hybridization depicts expression of (A,E)
hand2, (B,F) tbx5, (C,G) tbx20 and (D,H) nkx2.5 in
ventricles of adult Z-CAT fish 7 days post-injection (dpi) of
vehicle (A-D) or 4-HT (E-H). Expression of each gene is
enhanced in spared myocardium following injury (E-H,
arrowheads). (I-K) Expression of Tg(hand2:EGFP) (green)
highlights the activation of hand2 regulatory sequences
following injury. Images are single confocal slices of
ventricular tissue at 7 dpi (I,J) and 14 dpi (K); insets
demonstrate myosin heavy chain (MHC; red) localization in
hand2-expressing cells.
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population outside the heart tube; this difference may relate to the
conditional regulationofHand1 expression in thesemice,whichdonot
overexpress Hand1 within the SHF.
Finally, our data indicate that hand2 overexpression can impact
regenerative cardiomyocyte proliferation in the adult heart. These
findings implicate the induction of hand2 expression during
regeneration as a key component of the regenerative mechanism.
We speculate that the ability of Hand2 to increase reprogramming
efficiency of fibroblasts toward a cardiac fate (Song et al., 2012;
Nam et al., 2013) could be related to our observation that Hand2 can
enhance cardiomyocyte proliferation; alternatively, the function of
Hand2 during reprogramming could be a reflection of our observed
influences of Hand2 on myocardial progenitor specification or
proliferation. To distinguish between these possibilities, it will be
important to elucidate and compare the pathways regulated by
Hand2 in each of these contexts, as well as in other settings, such as
the Hand2-driven induction of hypertrophy in the postnatal mouse
myocardium (Dirkx et al., 2013). In the long term, these
investigations may allow further improvements in strategies for
cardiac reprogramming, regeneration and repair.
In addition to their implications regarding future applications for
Hand2 in regenerative medicine, our results provide intriguing insight
into possible causes of CHD. Duplications and deletions of the 4q33
chromosomal region, which contains HAND2, have been associated
with CHD (Borochowitz et al., 1997; Byatt et al., 1997). Moreover,
individuals with partial trisomy distal 4q (4q+ syndrome), a
translocation that involves duplication of HAND2 and neighboring
genes, exhibit striking cardiac and limb defects (Tamura et al., 2013).
In a mouse model for 4q+ syndrome, rebalancing levels ofHand2 by
breeding to Hand2-deficient animals ameliorated the heart and limb
phenotypes, implicating overexpression ofHand2 as a cause of these
defects (Tamura et al., 2013).Our data suggest possibleways inwhich
HAND2 overexpression could cause CHD through alteration of
cardiomyocyte production; future studies that elucidate the specific
Hand2 partners and targets involved in FHF specification, SHF
proliferation and cardiomyocyte proliferation will provide a deeper
understanding of the mechanisms through which Hand2 influences
the origins of CHD.
MATERIALS AND METHODS
Zebrafish and genotyping
We bred wild-type zebrafish, zebrafish heterozygous for the hand2 mutant
allele hans6 (Yelon et al., 2000) or zebrafish carrying Tg(-5.1myl7:
nDsRed2)f2 (Mably et al., 2003). In addition, we bred zebrafish carrying
Tg(nkx2.5:ZsYellow) (Zhou et al., 2011) or Tg(kdrl:GRCFP) (Cross et al.,
2003) to zebrafish carrying the newly generated transgenes described below,
and we employed adult zebrafish carrying Tg(hand2:EGFP)pd24 (Kikuchi
et al., 2011a). PCR genotyping of hans6 mutant embryos was conducted as
previously described (Yelon et al., 2000).
Injection of mRNA
We synthesized capped mRNA from a pCS2-hand2 plasmid using the
Ambion mMESSAGE mMACHINE kit, and we injected 160 pg hand2
mRNA into embryos at the one- to two-cell stage. The hand2 dimerization-
deficient (hand2 P) and DNA binding-deficient (hand2 EDE) constructs
were generated using the QuikChange II site-directed mutagenesis kit
(Agilent Technologies).
Creation of stable transgenic lines
To generate transgenes suitable for heat-activated overexpression of hand2,
we first amplified the hand2-coding sequence from the plasmids pCS2-
hand2, pCS2-hand2 P and pCS2-hand2 AA, and cloned these amplicons
into the p3xFLAG-CMV vector (Sigma) at the HindIII and XbaI restriction
sites. Each version of FLAG-hand2 was then introduced into the pENTR/
D-TOPO vector (Invitrogen). Each final transgene was achieved through a
Gateway LR reaction containing four plasmids: p5E-hsp70l (Kwan et al.,
2007), pDestTol2pA2 (Kwan et al., 2007), p3E-2A-mcherry-pA (Covassin
et al., 2009) and the appropriate pENTR/D-TOPO FLAG-hand2 plasmid.
We employed standard protocols to create transgenic founders (Fisher et al.,
2006). The F1 progeny of prospective founder fish were screened for mCherry
fluorescence following heat shock for 1 h at 37°C, and phenotypic analysis
wasperformedon the F1andF2progenyof promising founders.Wecompared
the phenotypes generated by heat shock of four lines carrying Tg(hsp70:
hand2), three lines carrying Tg(hsp70:hand2AA) and one line carrying
Tg(hsp70:hand2P), all of which exhibited qualitatively similar levels of
mCherry fluorescence. Followingheat shock at 10 hpf, embryos fromall of the
Tg(hsp70:hand2) and Tg(hsp70:hand2AA) lines exhibited similarly abnormal
cardiacmorphologyat 36 hpf. In addition, expressionofTg(hsp70:hand2) and
expression of Tg(hsp70:hand2AA) were both able to rescue heart tube
formation in hans6mutant embryos, whereas expression of Tg(hsp70:hand2P)
did not rescue. Results shown here use three specific transgenic lines:
Tg(hsp70:FLAG-hand2-2A-mCherry)sd28, Tg(hsp70:FLAG-hand2AA-2A-
mCherry)sd29 and Tg(hsp70:FLAG-hand2P-2A-mCherry)sd30.
To generate the transgenic line Tg(β-actin2:loxp-mCherry-STOP-loxp-
hand2)pd38, 5.3 kb of genomic DNA immediately upstream of the β-actin2
transcriptional start site was subcloned into a modified pBSK vector with a
multiple cloning site flanked by I-SceI restriction sites. A loxP-mCherry-
STOP-loxP-hand2 cassette was then subcloned downstream of the β-actin2
promoter. The mCherry-STOP cassette serves as a marker for the transgene
and also prevents read-through translation of Hand2 protein.
In situ hybridization
Whole-mount in situ hybridization was performed as previously described
(Thomas et al., 2008) using probes for cmlc2 (myl7; ZDB-GENE-991019-3),
mef2cb (ZDB-GENE-040901-7), islet1 (isl1; ZDB-GENE-980526-112), scl
(tal1; ZDB-GENE-980526-501), etsrp (etv2; ZDB-GENE-050622-14), pu.1
(spi1b; ZDB-GENE-980526-164), nkx2.5 (ZDB-GENE-980526-321) and
gata4 (ZDB-GENE-980526-476). Embryonic stages were determined by
counting somites prior to fixation. Areameasurementsweremade by using the
selection tool in ImageJ64 to score stained pixel area. Statistical analysis of
data sets was performed using Microsoft Excel to conduct unpaired t-tests.
We have found that cmlc2 area measurements at 18-20 somites correlate well
with counts of cell outlines in the same images (data not shown), making area
measurement a reasonable strategy for comparing estimated sizes of
cardiomyocyte populations.
Immunofluorescence
Whole-mount immunofluorescence was performed as previously described
(Thomas et al., 2008), using the monoclonal antibodies MF20 and S46
(Developmental Studies Hybridoma Bank), a polyclonal antibody against
Islet1 (GeneTex; GTX128201L) and the secondary antibodies goat anti-
mouse IgG2b FITC (Southern Biotech), goat anti-mouse IgG1 TRITC
(Southern Biotech) and goat anti-rabbit Alexa Fluor 488 (Molecular Probes).
The numbers of Islet1-positive nuclei within MF20-positive cells were
counted both in three-dimensional reconstructions and in optical sections.
Fluorescent in situ hybridization with immunofluorescence
Embryos were fixed in 2% formaldehyde for 20 min and then gently
agitated in 0.5% Triton and 0.2% saponin to dissolve the yolk. Embryos
were then fixed in 4% paraformaldehyde overnight at 4°C. An antisense
mef2cb probe was detected by deposition of TSA Plus fluorescein solution
(PerkinElmer), using an established protocol (Brend and Holley, 2009),
followed by MF20 antibody staining.
Cell counting and EdU incorporation
Cardiomyocyte counting in Tg(-5.1myl7:nDsRed2) embryos was performed
using an established protocol (Schoenebeck et al., 2007). Cell counting in
Tg(hsp70:FLAG-hand2-2A-mCherry) embryos was performed subsequent
to EdU incorporation, using a modification of a described protocol (Zeng
and Yelon, 2014). Dechorionated embryos were exposed to 10 mM EdU in
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0.3× Danieau buffer with 15% DMSO for 30 min on ice. After a series of
washes, embryos were incubated at 28.5°C until fixation. Embryos were
fixed in 2% formaldehyde for 20 min and then gently agitated in 0.5%
Triton and 0.2% saponin to dissolve the yolk, followed by fixation in 2%
formaldehyde overnight at 4°C. Embryos were then stained with the primary
antibody MF20 followed by an anti-mouse IgG secondary antibody
conjugated with either Alexa Fluor 488 or 647 (Invitrogen). EdU
incorporation was visualized using a Click-iT imaging kit (Invitrogen)
with either Alexa Fluor 594 or 647. Samples were then placed in SlowFade
Gold anti-fade reagent with DAPI (Molecular Probes). Cardiomyocyte
number was determined by examining DAPI-stained nuclei within MF20-
positive cells both in three-dimensional reconstructions and in optical
sections, and proliferation index was calculated as the percentage of these
cells that exhibited EdU localization. A similar method was used to
determine the number and proliferation index of Tg(nkx2.5:ZsYellow)-
expressing MF20-negative cells clustered near the arterial pole of the heart
tube. Statistical analysis of data sets was performed usingMicrosoft Excel to
conduct unpaired t-tests.
Imaging
Bright-field and fluorescent images were captured with a Zeiss Axiocam on
a Zeiss Axiozoom or a Zeiss Axioplan microscope, and processed using
Zeiss AxioVision and Adobe Creative Suite. Confocal z-stacks were
collected by a Leica SP5 confocal microscope and analyzed using Imaris
software (Bitplane).
Cardiac injury and histology
For cardiomyocyte ablation injury, we induced myocyte expression of
diphtheria toxin A in zebrafish carrying both the Tg(cmlc2:CreER)pd10
(Kikuchi et al., 2010) and Tg(β-actin2:loxp-mCherry-STOP-loxp-DTA)pd36
(Wang et al., 2011) transgenes; this combination is referred to as Z-CAT
(zebrafish cardiomyocyte ablation transgenes) (Wang et al., 2011).
Anesthetized Z-CAT fish were injected with 0.5 mg/ml 4-hydroxytamoxifen
(4-HT) in 10% ethanol orwith vehicle alone, as previously described (Kikuchi
et al., 2010). For ventricular resection injury, we performed surgeries as
described previously (Poss et al., 2002).
For analysis of paraformaldehyde-fixed hearts, in situ hybridization on
10 μm cryosections was performed as previously described (Poss et al.,
2002), using probes for hand2 (ZDB-GENE-000511-1), tbx5 (ZDB-GENE-
991124-7), nkx2.5 (ZDB-GENE-980526-321) and tbx20 (ZDB-GENE-
000427-7). Immunofluorescence with primary antibodies that recognize
myosin heavy chain (F59; Developmental Studies Hybridoma Bank) and
GFP (Invitrogen) was performed as previously described (Kikuchi et al.,
2011b). To determine cardiomyocyte proliferation indexes, we employed
established techniques for staining sections with antibodies against Mef2
(Santa Cruz Biotechnology) and PCNA (Sigma), and assessing the
proportion of Mef2-positive cells that are also PCNA positive (Wang
et al., 2011).
Acknowledgements
We thank K. Birnbaum, N. Chi, S. Evans, T. Evans, H. Knaut, R. Lehmann,
N. Tanese and members of the Yelon laboratory for thoughtful input.
Competing interests
The authors declare no competing financial interests.
Author contributions
Y.L.S., J.W., K.D.P. and D.Y. designed these studies; Y.L.S., K.M.G. and J.W.
performed experiments; B.A.F. and A.B.F. generated reagents; Y.L.S., K.M.G.,
J.W., K.D.P. and D.Y. analyzed the data; and Y.L.S. and D.Y. wrote the manuscript
with input from all authors.
Funding
This work was supported by grants to D.Y. from the National Institutes of Health
(NIH) [R01HL069594 and R01HL108599], the American Heart Association and the
March of Dimes; by a grant to K.D.P. from the NIH [R01HL081674]; and by grants to
A.B.F. from the NIH [R01HL122123, R01HL120920 and R01AR061392]. Y.L.S.
received support from an American Heart Association predoctoral fellowship
[10PRE3510044]. Deposited in PMC for release after 12 months.
Supplementary material
Supplementary material available online at
http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.106336/-/DC1
References
Borochowitz, Z., Shalev, S. A., Yehudai, I., Bar-El, H., Dar, H. and Tirosh, E.
(1997). Deletion (4)(q33 –> qter): a case report and review of the literature. J. Child
Neurol. 12, 335-337.
Brend, T. and Holley, S. A. (2009). Zebrafish whole mount high-resolution double
fluorescent in situ hybridization. J. Vis. Exp. 25, 1229.
Byatt, S. A., Baker, E., Richards, R. I., Roberts, C. and Smith, A. (1997).
Unbalanced t(4;11)(q32;q23) in a 34-year-old man with manifestations of distal
monosomy 11q and trisomy 4q syndromes. Am. J. Med. Genet. 70, 357-360.
Choi,W.-Y. and Poss, K. D. (2012). Cardiac regeneration.Curr. Top. Dev. Biol. 100,
319-344.
Covassin, L. D., Siekmann, A. F., Kacergis, M. C., Laver, E., Moore, J. C.,
Villefranc, J. A., Weinstein, B. M. and Lawson, N. D. (2009). A genetic screen
for vascular mutants in zebrafish reveals dynamic roles for Vegf/Plcg1 signaling
during artery development. Dev. Biol. 329, 212-226.
Cross, L. M., Cook, M. A., Lin, S., Chen, J.-N. and Rubinstein, A. L. (2003). Rapid
analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler.
Thromb. Vasc. Biol. 23, 911-912.
de Pater, E., Clijsters, L., Marques, S. R., Lin, Y.-F., Garavito-Aguilar, Z. V.,
Yelon, D. and Bakkers, J. (2009). Distinct phases of cardiomyocyte
differentiation regulate growth of the zebrafish heart. Development 136,
1633-1641.
Dirkx, E., Gladka, M. M., Philippen, L. E., Armand, A.-S., Kinet, V., Leptidis, S.,
el Azzouzi, H., Salic, K., Bourajjaj, M., da Silva, G. J. J. et al. (2013). Nfat and
miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat.
Cell Biol. 15, 1282-1293.
Fahed, A. C., Gelb, B. D., Seidman, J. G. and Seidman, C. E. (2013). Genetics of
congenital heart disease: the glass half empty. Circ. Res. 112, 707-720.
Firulli, B. A., Howard, M. J., McDaid, J. R., McIlreavey, L., Dionne, K. M.,
Centonze, V. E., Cserjesi, P., Virshup, D. M. and Firulli, A. B. (2003). PKA,
PKC, and the protein phosphatase 2A influence HAND factor function: a
mechanism for tissue-specific transcriptional regulation.Mol. Cell 12, 1225-1237.
Firulli, B. A., Krawchuk, D., Centonze, V. E., Vargesson, N., Virshup, D. M.,
Conway, S. J., Cserjesi, P., Laufer, E. and Firulli, A. B. (2005). Altered Twist1
and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb
abnormalities. Nat. Genet. 37, 373-381.
Firulli, B. A., McConville, D. P., Byers, J. S., III, Vincentz, J.W., Barnes, R. M. and
Firulli, A. B. (2010). Analysis of a Hand1 hypomorphic allele reveals a critical
threshold for embryonic viability. Dev. Dyn. 239, 2748-2760.
Fisher, S., Grice, E. A., Vinton, R. M., Bessling, S. L., Urasaki, A., Kawakami, K.
and McCallion, A. S. (2006). Evaluating the biological relevance of putative
enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat.
Protoc. 1, 1297-1305.
Garavito-Aguilar, Z. V., Riley, H. E. and Yelon, D. (2010). Hand2 ensures an
appropriate environment for cardiac fusion by limiting Fibronectin function.
Development 137, 3215-3220.
Gupta, V., Gemberling, M., Karra, R., Rosenfeld, G. E., Evans, T. and Poss, K. D.
(2013). An injury-responsive gata4 program shapes the zebrafish cardiac
ventricle. Curr. Biol. 23, 1221-1227.
Halloran, M. C., Sato-Maeda, M., Warren, J. T., Su, F., Lele, Z., Krone, P. H.,
Kuwada, J. Y. and Shoji, W. (2000). Laser-induced gene expression in specific
cells of transgenic zebrafish. Development 127, 1953-1960.
Hinits, Y., Pan, L., Walker, C., Dowd, J., Moens, C. B. and Hughes, S. M. (2012).
Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field
cardiomyocyte differentiation. Dev. Biol. 369, 199-210.
Jopling, C., Sleep, E., Raya, M., Martı,́ M., Raya, A. and Izpisúa Belmonte, J. C.
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Supplemental Figure S1.  Mouse and zebrafish Hand2 protein sequences are highly conserved. Alignment of amino acid sequences 
of mouse Hand2 (NP_034532.3; top row) and zebrafish Hand2 (AAI65015.1; bottom row), generated through pairwise BLASTP 
(Altschul et al., 1997).  Identical and similar amino acids are indicated in the middle row.  The three arginines replaced in the DNA 
binding-deficient form of Hand2 (Hand2 EDE) are shown in red.  The phenylalanine replaced in the dimerization-deficient form of Hand2 
(Hand2 P) is shown in green.  The threonine and serine replaced in the phosphorylation-deficient form of Hand2 (Hand2 AA) are shown in blue. 
Supplemental Figure S2. Induction of hand2 overexpression at 10 hpf, but not at 24 hpf, produces a morphologically evident 
cardiac phenotype. (A-F) Lateral views of live embryos at 36 hpf depict (A-C) embryonic morphology and (D-F) mCherry fluorescence 
in (A,D) a nontransgenic embryo and (B,C,E,F) embryos carrying the transgene Tg(hsp70:FLAG-hand2-2A-mCherry) (abbreviated as 
Tg(hsp70:hand2)), after heat shock at (A,B,D,E) 10 hpf (tail bud) or (C,F) 24 hpf.  Heat shock of transgenic embryos at 10 hpf leads 
to pericardial edema (B), and residual mCherry fluorescence is still evident in these embryos at 36 hpf (E).  In contrast, edema is not 
observed in transgenic embryos after heat shock at 24 hpf (C); mCherry fluorescence remains pervasive in these embryos at 36 hpf (F). 
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Supplemental Figure S3. Levels of protein production in different transgenic lines. (A-H) Lateral views of live embryos at 30 
hpf depict bright field images of representative embryos from different transgenic lines (A-D), along with corresponding mCherry 
fluorescence (E-H). (E) No mCherry fluorescence is induced in heat-shocked nontransgenic embryos. (F-H) mCherry fluorescence 
is readily detectable in representative embryos carrying the transgenes (F) Tg(hsp70:FLAG-hand2-2A-mCherry) (Tg(hsp70:hand2)), 
(G) Tg(hsp70:FLAG-hand2P-2A-mCherry) (Tg(hsp70:hand2P)), and (H) Tg(hsp70:FLAG-hand2AA-2A-mCherry) (Tg(hsp70:hand2AA)).
(I) Western blot analysis compares levels of FLAG-tagged Hand2 protein in different transgenic lines.  Embryos were deyolked 
and lysates were prepared as previously described (Link et al., 2006), and blots were probed with either a monoclonal anti-FLAG 
M2 antibody (F1804, Sigma, 1:2000) or a monoclonal anti-α-Tubulin antibody (T6728, Sigma, 1:10,000), followed by a rabbit 
anti-mouse IgG HRP-conjugated secondary antibody (ab97046, Abcam, 1:10,000).  Proteins were visualized using SuperSignal West 
Femto Chemiluminescent Substrate (Thermo Scientific).  Each lane contains lysate from 15 embryos at 36 hpf (2 hours following heat 
shock), and the lanes compare protein levels in nontransgenic embryos (WT), Tg(hsp70:hand2) embryos (hand2), Tg(hsp70:hand2P) 
embryos (hand2P), and Tg(hsp70:hand2AA) embryos (hand2AA).  All three transgenic lines contain a ~23 kD FLAG-Hand2 
protein, with comparable levels in Tg(hsp70:hand2) and Tg(hsp70:hand2AA) embryos and lower levels in Tg(hsp70:hand2P) embryos. 
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Supplemental Figure S4. Normal islet1 expression at the venous pole in embryos overexpressing hand2. (A-B) 
Immunofluorescence at 36 hpf for MF20 (red, visible throughout the heart) and Islet1 (green, visible in the nuclei of a subset of atrial 
cells).  Frontal views, dorsal to the top; arrows point to the Islet1-positive population at the venous pole of the atrium.  Following heat 
shock at 10 hpf, the population of Islet1-positive cells at the venous pole appears similar in hearts from (A) nontransgenic embryos and 
(B) Tg(hsp70:hand2) embryos. (C) Bar graph compares average number of Islet1-positive cardiomyocytes at 36 hpf in nontransgenic 
embryos and Tg(hsp70:hand2)embryos, following heat shock at 10 hpf.  Error bars indicate standard deviation; no significant difference 
is observed between these two data sets (n=12, p=0.09). (D-E) In situ hybridization depicts islet1 expression at 36 hpf, following heat 
shock at 10 hpf.  Frontal views, dorsal to the top; arrows point to the ring of islet1-expressing cells at the venous pole of the atrium. 
Expression patterns are similar in (D) nontransgenic embryos and (E) Tg(hsp70:hand2) embryos.  
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Supplemental Figure S5. No evident influence of hand2 overexpression on cardiomyocyte proliferation after initial heart 
tube assembly. (A-F) EdU incorporation in hearts of (A-C) nontransgenic and (D-F) Tg(hsp70:hand2) embryos at 36 hpf, following 
heat shock at 10 hpf and EdU pulse at 23 hpf; (A,C,D,F) partial reconstructions of confocal z-stacks with ventricle up and (B,E) 
representative single slices.  Dots, arrows, and color schemes are as described for Fig. 5A-F.  Note that the nontransgenic heart shown 
(A) contains a number of EdU-positive blood cells that were trapped during fixation; EdU-positive blood cells are less commonly 
observed within the hearts of hand2-overexpressing embryos (D), due to their impaired circulation. (G) Timeline of experimental 
design. (H) Bar graph compares proliferation indexes in nontransgenic (mCherry-negative) and Tg(hsp70:hand2) (mCherry-positive) 
embryos, as in Fig. 5H.  No change in proliferation index is seen in hand2-overexpressing embryos (n=8-11; p=0.196).
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Supplemental Figure S6. No evident influence of hand2 overexpression on cardiomyocyte proliferation within the heart tube at 
23 hpf. (A-D) EdU incorporation in hearts of (A,B) nontransgenic and (C,D) Tg(hsp70:hand2) embryos at 23 hpf, following heat shock 
at 10 hpf and EdU pulse at 17 hpf; partial reconstructions of confocal z-stacks.  Images depict the elongating cardiac cone, positioned 
with its arterial end toward the top.  (A,C) White dots indicate EdU-positive (red) cells that are also MF20-positive (green) differentiated 
cardiomyocytes.  (B,D) White dots indicate all nuclei (DAPI, blue) of myocardial cells, including both EdU-positive and EdU-negative 
cardiomyocytes. (E) Timeline of experimental design. (F) Bar graph compares proliferation indexes in nontransgenic (mCherry- 
negative) and Tg(hsp70:hand2) (mCherry-positive) embryos, as in Fig. 5H.  No change in proliferation index is seen in hand2- 
overexpressing cardiomyocytes (n=10-11; p=0.252).  Similarly, when we assessed EdU incorporation in hand2-overexpressing 
embryos at 26 hpf, following heat shock at 10 hpf and EdU pulse at 14 hpf, we did not see an increased proliferation index in hand2- 
overexpressing cardiomyocytes (proliferation index of 28 ± 4% in nontransgenic embryos compared to proliferation index of 27 ± 4% 
in hand2-overexpressing embryos; n=7-10, p=0.58).  
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Supplemental Figure S7. Endocardium is present in embryos overexpressing hand2. (A-H) Lateral views of live embryos at 
30 hpf depict (A-B) embryonic morphology and (C-H) expression of the transgene Tg(kdrl:GRCFP) in the vasculature of (A,C,E,F) 
nontransgenic embryos and (B,D,G,H) Tg(hsp70:hand2) embryos, following heat shock at 10 hpf. (C-D) General vascular patterning 
and sprouting of intersomitic vessels (inset) is intact in embryos overexpressing hand2 (D). (E-H) Partial reconstructions of confocal 
z-stacks (E,G) and representative single slices (F,H) highlight the endocardium (arrows): just as in nontransgenic embryos (E,F), a thin 
layer of endocardial tissue lines the entire heart tube in embryos overexpressing hand2 (G,H).  
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